Objective: To investigate the effect of the reconstitution methods for the
commercial amphotericin B preparation with respect to particulate contamina
tion.
Methods: The particle counts in amphotericin B solutions reconstituted acco
rding to three different methods and amphotericin B fluids made with intrav
enous fluids after reconstitution were performed using a light extinction m
ethod. The particle contaminants were identified with X-ray emission spectr
ometry attached to a scanning electron microscope.
Results: Amphotericin B in a vial induced particle contamination during the
reconstitution process, and the contamination was especially marked by sha
king vigorously after injecting water into the vial. From the X-ray analysi
s, it appeared that the increased number of particles was derived from the
amphotericin B-deoxycholate complex containing substances such as silicone
released from the vial components. Amphotericin B fluid made with intraveno
us fluids after reconstitution also contained particles over the acceptable
limits according to the Japanese or US pharmacopoeia.
Conclusion: These findings suggest that reconstituted solutions should be f
iltered with membrane filters and diluted fluids with in-line filters.